CN1305510C - Medicine for treating intractable fever - Google Patents
Medicine for treating intractable fever Download PDFInfo
- Publication number
- CN1305510C CN1305510C CNB2005100180166A CN200510018016A CN1305510C CN 1305510 C CN1305510 C CN 1305510C CN B2005100180166 A CNB2005100180166 A CN B2005100180166A CN 200510018016 A CN200510018016 A CN 200510018016A CN 1305510 C CN1305510 C CN 1305510C
- Authority
- CN
- China
- Prior art keywords
- parts
- weight portions
- radix
- medicine
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 40
- 229940079593 drug Drugs 0.000 title claims abstract description 23
- 241000255791 Bombyx Species 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 15
- 210000003038 endothelium Anatomy 0.000 claims description 15
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 14
- 241000555712 Forsythia Species 0.000 claims description 12
- 241001180876 Saposhnikovia Species 0.000 claims description 12
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 4
- 210000004072 lung Anatomy 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 208000021760 high fever Diseases 0.000 abstract 2
- 241000282817 Bovidae Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 241000530075 Clerodendrum bungei Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 240000005729 Cylindropuntia imbricata Species 0.000 abstract 1
- 235000001427 Cylindropuntia imbricata Nutrition 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241000229179 Ledebouriella Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000011505 plaster Substances 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000003672 processing method Methods 0.000 description 8
- 208000030208 low-grade fever Diseases 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010004542 Bezoar Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating intractable high fever and low fever with natural raw material as raw material, which is prepared from 10 to 30 weight portions of bupleurum root, 10 to 30 weight portions of many-flowered glory-bower, 10 to 30 weight portions of weeping forsythia capsule, 30 to 90 weight portions of corn stigma, 10 to 30 weight portions of herba artemisiae, 10 to 30 weight portions of wolfberry bark, 3 to 5 weight portions of antelope, 30 to 50 weight portions of cholla stem, 6 to 18 weight portions of safflower, 10 to 27 weight portions of hemlock parsley, 10 to 30 weight portions of stiff silkorm, 10 to 30 weight portions of ledebouriella root, 10 to 20 weight portions of chicken's gizzard-membrane and 10 to 50 weight portions of plaster. The raw material is prepared into the required conventional types of medicines by purification, impurity removal, drying, pulverization and sieving by an 80 to 100 mesh sieve. The medicine for treating intractable high fever and low fever is suitable for female and male patients of all ages with internal heat accumlation, external heat affection, wind heat, vacuity heat, excess heat, cold heat, liver fire, stomach fire, heart fire; heart fire, lung fire and lung heat, has obvious effect and is popular with patients and patients' families.
Description
Technical field
The present invention relates to a kind of is the Chinese medicine of raw material with the natural material medicine, particularly relates to a kind of medicine for the treatment of intractable fever, belongs to the field of Chinese medicines.
Background technology
High low grade fever is human common susceptible diseases, and the pathogeny of self is that patient's autoimmunity is poor, opposing quality is low, be subject to extraneously infect or infect, and the state of an illness has gently to be had heavily, symptom have have by force a little less than and individual's body constitution and spiritual quality substantial connection is arranged.Live in the natural environment, all existence in degeneration-resistant of majority, high low grade fever is again the guide of some serious disease, does not heal for a long time, the meeting serious harm is healthy, even threat to life.
For the fever that causes by a variety of causes, doctor trained in Western medicine generally takes aspirin or penicillin to bring down a fever, these two kinds of medicines acquire a certain degree of difficulty to the fever that diseases caused by exogenous pathogenic factor cause, if but because of the diseases caused by exogenous pathogenic factor internal injury, inside and outside interweave, then treatment just acquires a certain degree of difficulty, and long-time the application can produce certain toxic and side effects, injection for curing brings the spirit and the misery of the human body for the patient again, and Physical temperature-lowering speed is slow, controls in table do not control, traditional Chinese medical science prescription is more, as Radix Bupleuri liver soothing soup, SIWU TANG, hyperpyrexia there is certain curative effect, but not good enough to the superelevation burning effect of cause of disease complexity.At present, being badly in need of a kind of medicine that can treat intractable fever comes out.
Summary of the invention
The objective of the invention is: overcome the deficiency of current existing medical technology, a kind of medicine that can treat intractable fever is provided.
Technical scheme of the present invention is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed Radix Bupleuri 10-30 part with the weight portion, Radix Clerodenri Cyrtophylli 10-30 part, Fructus Forsythiae 10-30 part, Stigma Maydis 30-90 part, Herba Artemisiae Scopariae 10-30 part, Cortex Lycii 10-30 part, Saigae Tataricae 3-5 part, Radix et Caulis Opuntiae Dillenii 30-50 part, Flos Carthami 6-18 part, Rhizoma Chuanxiong 10-27 part, Bombyx Batryticatus 10-30 part.
The medicine of described treatment intractable fever also contains Radix Saposhnikoviae 10-30 part, Endothelium Corneum Gigeriae Galli 10-20 part, Gypsum Fibrosum 10-50 part.
The optimization of C of the medicine of described treatment intractable fever is: by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri, 30 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 30 parts of Fructus Forsythiaes, 80 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 40 parts in Gypsum Fibrosum.
The optimum formula of the medicine of described treatment intractable fever is: by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri, 30 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 30 parts of Fructus Forsythiaes, 75 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Gypsum Fibrosum.
Positive effect intentionally of the present invention is:
1. the medicine of treatment intractable fever of the present invention, though inner product heat, outer sensible heat, wind heat, deficiency-heat, excess-heat, alternate attack of chill and fever, liver-fire, stomach-fire, heart-fire, lung-fire, lung-heat, of all ages, regardless of sex, ill equal can the use, just apparent in view with primary effect, all can bring down a fever in 1-3 hour after the medication, effect is obvious, is subjected to the favorable comment of patient and family numbers of patients deeply.
2. the medicine of treatment intractable fever of the present invention, compare with similar technology: bring down a fever obviously, thoroughly, curative effect is lasting, than tablet: dipyrone, acetaminophen, cow-bezoar bolus for resurrection; Injection: the Radix Bupleuri pin, the heat-clearing and toxic substances removing pin, QINGKAILING, penicillin, streptomycin, the effect of prompt mycin is all good, and curative effect is lasting.
3. the medicine of treatment intractable fever of the present invention, processing technique is simple, can be prepared into conventional various dosage forms, satisfies all kinds of patients' demand.
The medicine of treatment intractable fever of the present invention, with Radix Bupleuri, Radix Clerodenri Cyrtophylli, Fructus Forsythiae, Stigma Maydis, Herba Artemisiae Scopariae, Cortex Lycii, Saigae Tataricae, Radix et Caulis Opuntiae Dillenii is monarch drug, can control outer sensible heat, inner product heat, interior damp and hot, lung qi dispersing is warm, separate pyretic toxicity, clearing away heart-fire, the liver-fire of dispelling, the removing heat from blood eliminating stagnation, inducing Ying heat into Qi phase, strengthening vital QI to eliminate pathogenic factors; Ministerial drug: Flos Carthami, Rhizoma Chuanxiong, Bombyx Batryticatus strengthen the blood-activating and qi-promoting dispelling wind-evil and transforming calculus, the clots absorbing pain relieving; Adjuvant drug: Radix Saposhnikoviae, Endothelium Corneum Gigeriae Galli, warm and not dry, induce sweat promoting digestion and removing stagnation, spleen invigorating fortune stomach in falling; Attached relieving restlessness is quenched the thirst so that medical gypsum is strengthened clearing away heat-fire, and the lung-heat stomach-fire is removed entirely.
Clinical experimental study:
A: case is selected: from the hospital at inventor place, selects from 20 days to 60 years old, the course of disease from week to three month, through all unfavorable patient's 49 examples of several different methods therapeutic effect, and male's 24 examples wherein, women's 25 examples, male, women patient's ratio is about 1: 1.
B: instructions of taking: every day, twice, 5-10 restrained, the 7-30 days course of treatment.
C: curative effect determinate standard:
Recovery from illness: the high or low heat of patient is moved back, keeps the heat that do not recur more than two weeks, shows that the patient fully recovers.
Produce effects: the high or low heat of patient is moved back, keeps having had after 10-24 hour heat, and not other side effect prove produce effects.
Effectively: the high or low heat of patient is moved back, keeps playing heat again after 4-6 hour, proves that we effectively.
Invalid: the patient takes that high low grade fever does not still subtract after our 3-4 hour, former disease as before, we are considered as invalid.
D: therapeutic outcome:
| Clinical manifestation | Recovery from illness | Produce effects | Effectively | Invalid |
| Patient's number | 33 | 12 | 4 | 0 |
| Ratio | 67.3％ | 24.5％ | 8.2％ | 0 |
E: discussion of results:
1. the medicine of treatment intractable fever of the present invention, if the equal energy of high low grade fever usefulness, though inner product heat, outer sensible heat, wind heat, deficiency-heat, excess-heat, alternate attack of chill and fever; Liver-fire, stomach-fire, heart-fire, lung-fire, lung-heat, equal can the use of all ages, regardless of sex, ill all can be brought down a fever after the medication in 1-3 hour.
2. the patient is before the Drug therapy with treatment intractable fever of the present invention, all sense heatings (high or low), lethargy, mood is not smooth, it is not good to express one's feelings, aversion to wind is afraid of cold, and fear of cold is afraid of moving, and is heavy then be unable to leave the bed, not feel at ease, even talking nonsense, after taking medicine 1-3 hour with we treatment, stable disease, heat is moved back, psychology is comfortable, ataraxy, and hungry person can eat, the lighter is promptly healed, heavyly then maintain a week back rehabilitation, prove that the curative effect of medication of treatment intractable fever of the present invention is true and reliable, can satisfy patient's demand.
The specific embodiment:
Embodiment one: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 10 parts of Radix Bupleuri with the weight portion, 10 parts of Radix Clerodenri Cyrtophyllis, 10 parts of Fructus Forsythiaes, 30 parts of Stigma Maydis, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Cortex Lycii, 3 parts of Saigae Tataricaes, 30 parts of Radix et Caulis Opuntiae Dilleniis, 6 parts on Flos Carthami, 10 parts of Rhizoma Chuanxiongs, 10 parts of Bombyx Batryticatus, 10 parts of Radix Saposhnikoviaes, 10 parts of Endothelium Corneum Gigeriae Galli, 10 parts in Gypsum Fibrosum.
Treatment intractable fever medicine processing method recited above: with described bulk drugs purification, roguing, oven dry, pulverizing, cross the 80-100 mesh sieve, make regular dosage form.
Described regular dosage form is a powder, or is pill, or is capsule, or is water preparation, or is granule.
The instructions of taking of treatment intractable fever medicine recited above is: every day, twice, 5-10 restrained, the 7-30 days course of treatment
Embodiment two: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri, 30 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 30 parts of Fructus Forsythiaes, 80 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 40 parts in Gypsum Fibrosum.
Embodiment three: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri, 30 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 30 parts of Fructus Forsythiaes, 75 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Gypsum Fibrosum.
Embodiment four: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri, 30 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 30 parts of Fructus Forsythiaes, 90 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 50 parts in Gypsum Fibrosum.
Embodiment five: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 20 parts of Radix Bupleuri, 20 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 20 parts of Fructus Forsythiaes, 50 parts of Stigma Maydis, 20 parts of Herba Artemisiae Scopariaes, 20 parts of Cortex Lycii, 4 parts of Saigae Tataricaes, 40 parts of Radix et Caulis Opuntiae Dilleniis, 10 parts on Flos Carthami, 15 parts of Rhizoma Chuanxiongs, 20 parts of Bombyx Batryticatus, 20 parts of Radix Saposhnikoviaes, 15 parts of Endothelium Corneum Gigeriae Galli, 25 parts in Gypsum Fibrosum.
Embodiment six: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 25 parts of Radix Bupleuri, 15 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 20 parts of Fructus Forsythiaes, 45 parts of Stigma Maydis, 15 parts of Herba Artemisiae Scopariaes, 25 parts of Cortex Lycii, 3 parts of Saigae Tataricaes, 35 parts of Radix et Caulis Opuntiae Dilleniis, 12 parts on Flos Carthami, 20 parts of Rhizoma Chuanxiongs, 15 parts of Bombyx Batryticatus, 25 parts of Radix Saposhnikoviaes, 18 parts of Endothelium Corneum Gigeriae Galli, 28 parts in Gypsum Fibrosum.
Embodiment seven: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 15 parts of Radix Bupleuri, 25 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 20 parts of Fructus Forsythiaes, 60 parts of Stigma Maydis, 28 parts of Herba Artemisiae Scopariaes, 24 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 42 parts of Radix et Caulis Opuntiae Dilleniis, 16 parts on Flos Carthami, 22 parts of Rhizoma Chuanxiongs, 17 parts of Bombyx Batryticatus, 23 parts of Radix Saposhnikoviaes, 12 parts of Endothelium Corneum Gigeriae Galli, 36 parts in Gypsum Fibrosum.
Embodiment eight: present embodiment medicine processing method and take method with embodiment one, and something in common does not repeat, and difference is: a kind of medicine for the treatment of intractable fever, by following be that the crude drug of unit is formed 20 parts of Radix Bupleuri, 19 parts of Radix Clerodenri Cyrtophyllis with the weight portion, 29 parts of Fructus Forsythiaes, 75 parts of Stigma Maydis, 19 parts of Herba Artemisiae Scopariaes, 26 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 34 parts of Radix et Caulis Opuntiae Dilleniis, 8 parts on Flos Carthami, 16 parts of Rhizoma Chuanxiongs, 27 parts of Bombyx Batryticatus, 20 parts of Radix Saposhnikoviaes, 15 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Gypsum Fibrosum.
Claims (4)
1. medicine for the treatment of intractable fever, it is characterized in that: with the weight portion is unit, contains Radix Bupleuri 10-30 part, Radix Clerodenri Cyrtophylli 10-30 part, Fructus Forsythiae 10-30 part, Stigma Maydis 30-90 part, Herba Artemisiae Scopariae 10-30 part, Cortex Lycii 10-30 part, Saigae Tataricae 3-5 part, Radix et Caulis Opuntiae Dillenii 30-50 part, Flos Carthami 6-18 part, Rhizoma Chuanxiong 10-27 part, Bombyx Batryticatus 10-30 part.
2. the medicine of treatment intractable fever according to claim 1 is characterized in that: also contain Radix Saposhnikoviae 10-30 part, Endothelium Corneum Gigeriae Galli 10-20 part, Gypsum Fibrosum 10-50 part.
3. the medicine of treatment intractable fever according to claim 1 and 2 is characterized in that: by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri with the weight portion, 30 parts of Radix Clerodenri Cyrtophyllis, 30 parts of Fructus Forsythiaes, 80 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 40 parts in Gypsum Fibrosum.
4. the medicine of treatment intractable fever according to claim 1 and 2 is characterized in that: by following be that the crude drug of unit is formed 30 parts of Radix Bupleuri with the weight portion, 30 parts of Radix Clerodenri Cyrtophyllis, 30 parts of Fructus Forsythiaes, 75 parts of Stigma Maydis, 30 parts of Herba Artemisiae Scopariaes, 30 parts of Cortex Lycii, 5 parts of Saigae Tataricaes, 50 parts of Radix et Caulis Opuntiae Dilleniis, 18 parts on Flos Carthami, 27 parts of Rhizoma Chuanxiongs, 30 parts of Bombyx Batryticatus, 30 parts of Radix Saposhnikoviaes, 20 parts of Endothelium Corneum Gigeriae Galli, 30 parts in Gypsum Fibrosum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100180166A CN1305510C (en) | 2005-09-20 | 2005-09-20 | Medicine for treating intractable fever |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100180166A CN1305510C (en) | 2005-09-20 | 2005-09-20 | Medicine for treating intractable fever |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739745A CN1739745A (en) | 2006-03-01 |
| CN1305510C true CN1305510C (en) | 2007-03-21 |
Family
ID=36092370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100180166A Expired - Fee Related CN1305510C (en) | 2005-09-20 | 2005-09-20 | Medicine for treating intractable fever |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305510C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104998090A (en) * | 2015-08-25 | 2015-10-28 | 费尔新 | Traditional Chinese medicine for treating infantile fever |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1456311A (en) * | 2003-03-17 | 2003-11-19 | 陈武德 | The four seasons cold oral liquid and preparing method therof |
-
2005
- 2005-09-20 CN CNB2005100180166A patent/CN1305510C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1456311A (en) * | 2003-03-17 | 2003-11-19 | 陈武德 | The four seasons cold oral liquid and preparing method therof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1739745A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441081B (en) | Medicament for treating gout and its preparation method | |
| CN100998843A (en) | Medicinal composition for treating cholecystitis | |
| CN101036777A (en) | Oral Chinese traditional medicine composition for treating chronic enteritis | |
| CN101537060B (en) | Medicine for treating AIDS | |
| CN102488784A (en) | Traditional Chinese medicine composition for treating low back pain | |
| CN101530516B (en) | Chinese medicament for treating appendicitis | |
| CN1305510C (en) | Medicine for treating intractable fever | |
| CN104706839A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis | |
| CN105596771A (en) | Method for preparing medicine for treating latent glomerulonephritis | |
| CN106377716A (en) | Traditional Chinese medicine composition for treating dysentery | |
| CN1305517C (en) | Mastoproliferation treating medicine | |
| CN109248280A (en) | Traditional Chinese medicine composition for treating emphysema and preparation method thereof | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN1745839A (en) | Compound Chinese medicine for gout | |
| CN101385836B (en) | Traditional Chinese medicine composition containing poria cocos for treating dermatomyositis and preparation thereof | |
| CN101385812B (en) | Traditional Chinese medicine composition containing epimeddium for treating dermatomyositis and preparation thereof | |
| CN106822734A (en) | A kind of numbness relieving and pain relieving externally used medicine bag | |
| CN107137591A (en) | A kind of Chinese medicine composition for treating atrophy disease | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN105267683A (en) | Chinese medical preparation for treating yin deficiency and poison type perianal and perirectal abscesses | |
| CN1214799C (en) | Medicine for treating sciatic nerve diseases | |
| CN104666824A (en) | Traditional Chinese medicinal composition for treating psoriasis | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN1218735C (en) | Medicine composition for treating pain in waist and lower limbs and hyperosteogeny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |